Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-22

Clinical Trial Update: Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial. [Phase 3]

View source ↗

Summary

Phase 3 randomized controlled trial evaluating two intravenous magnesium sulfate doses (vs standard single dose) with or without nebulized budesonide for severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Bronchial Asthma | Phase 3 | Status: UNKNOWN